Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Flaherty

Showing results (91-100 of 714) with videos related to

Pageof 72
Sort By:
Journal of Travel Medicine|March 30, 2017
Fasten your seatbelts: preventing injury from air turbulence in travellersGerard T Flaherty, Séamus M Lehane
Journal of Travel Medicine|October 23, 2018
Tuning into the travel health risks of music tourismTimothy S Lu, Gerard T Flaherty
Current Oncology Reports|March 2, 2006
Her-2 targeted therapy: beyond breast cancer and trastuzumabKeith T Flaherty, Marcia S Brose
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
Sorafenib-Related Hand-Foot Skin Reaction Improves, Not Worsens, with Continued TreatmentKeith T Flaherty, Marcia S Brose
Journal of Travel Medicine|November 27, 2018
The significance of non-communicable threats to travellers: time for a sea-change?Christopher A Sanford, Gerard T Flaherty
The British Journal of Dermatology|January 22, 2014
Major therapeutic developments and current challenges in advanced melanomaR J Sullivan, K T Flaherty
Klinische Wochenschrift|December 15, 1991
Role of oxygen radicals in myocardial reperfusion injury: experimental and clinical evidenceJ T Flaherty, J L Zweier
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Response to Immune Checkpoint Antibodies: Not All Responses Are Created EqualJustine V Cohen, Keith T Flaherty
Nature Reviews. Clinical Oncology|September 30, 2015
Immunotherapy: Anti-PD-1 therapies-a new first-line option in advanced melanomaRyan J Sullivan, Keith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2015
Pembrolizumab for Treatment of Patients with Advanced or Unresectable MelanomaRyan J Sullivan, Keith T Flaherty
Pageof 72

Showing results (91-100 of 714) with videos related to

Sort By:
Pageof 72
Journal of Travel Medicine|March 30, 2017
Fasten your seatbelts: preventing injury from air turbulence in travellersGerard T Flaherty, Séamus M Lehane
Journal of Travel Medicine|October 23, 2018
Tuning into the travel health risks of music tourismTimothy S Lu, Gerard T Flaherty
Current Oncology Reports|March 2, 2006
Her-2 targeted therapy: beyond breast cancer and trastuzumabKeith T Flaherty, Marcia S Brose
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
Sorafenib-Related Hand-Foot Skin Reaction Improves, Not Worsens, with Continued TreatmentKeith T Flaherty, Marcia S Brose
Journal of Travel Medicine|November 27, 2018
The significance of non-communicable threats to travellers: time for a sea-change?Christopher A Sanford, Gerard T Flaherty
The British Journal of Dermatology|January 22, 2014
Major therapeutic developments and current challenges in advanced melanomaR J Sullivan, K T Flaherty
Klinische Wochenschrift|December 15, 1991
Role of oxygen radicals in myocardial reperfusion injury: experimental and clinical evidenceJ T Flaherty, J L Zweier
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Response to Immune Checkpoint Antibodies: Not All Responses Are Created EqualJustine V Cohen, Keith T Flaherty
Nature Reviews. Clinical Oncology|September 30, 2015
Immunotherapy: Anti-PD-1 therapies-a new first-line option in advanced melanomaRyan J Sullivan, Keith T Flaherty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2015
Pembrolizumab for Treatment of Patients with Advanced or Unresectable MelanomaRyan J Sullivan, Keith T Flaherty
Pageof 72